Literature DB >> 17280667

Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid.

M Lipovac1, C Kurz, F Reithmayr, H C Verhoeven, J C Huber, M Imhof.   

Abstract

OBJECTIVE: To evaluate the efficacy of vesical instillation of hyaluronic acid against recurrent urinary tract infections.
METHODS: Twenty women with a history of recurrent urinary tract infections each received 9 intravesical instillations of hyaluronic acid over 6 months. Their status was assessed prospectively over 47.6 weeks and compared with a retrospective review of patient charts covering 36.2+/-6.2 weeks.
RESULTS: The total numbers of urinary tract infections were 67 before and 10 after treatment (p<0.001). Thirteen patients (65%) were free of recurrences until the end of the study. One had a recurrence during treatment, and 6 (30%) during follow-up. The number of infections per year per patient was reduced from 4.99+/-0.92 to 0.56+/-0.82 (p<0.001). In women with recurrences, time to recurrence was 178.3+/-25.5 days, compared with 76.7+/-24.6 days before treatment (p<0.001).
CONCLUSION: Intravesical instillation of hyaluronic acid is effective in preventing recurrent urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280667     DOI: 10.1016/j.ijgo.2006.11.025

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  15 in total

1.  Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey.

Authors:  Antonio Cicione; Francesco Cantiello; Giuseppe Ucciero; Andrea Salonia; Marco Torella; Marco De Sio; Riccardo Autorino; Antonio Carbone; Martin Romancik; Roman Tomaskin; Rocco Damiano
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

2.  Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.

Authors:  Davide De Vita; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-05-22       Impact factor: 2.894

3.  The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease.

Authors:  Rocco Damiano; Antonio Cicione
Journal:  Ther Adv Urol       Date:  2011-10

4.  Prevention of recurrent urinary tract infections by intravesical administration of heparin: a pilot study.

Authors:  Tova Ablove; Manish Patankar; Songwon Seo
Journal:  Ther Adv Urol       Date:  2013-12

5.  Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis.

Authors:  Davide De Vita; Henrik Antell; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-11-06       Impact factor: 2.894

Review 6.  Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.

Authors:  Massimo Lazzeri; Rodolfo Hurle; Paolo Casale; NicolòMaria Buffi; Giovanni Lughezzani; Girolamo Fiorini; Roberto Peschechera; Luisa Pasini; Silvia Zandegiacomo; Alessio Benetti; Gianluigi Taverna; Giorgio Guazzoni; Guido Barbagli
Journal:  Ther Adv Urol       Date:  2015-12-16

7.  The clinical effectiveness of intravesical sodium hyaluronate (cystistat®) in patients with interstitial cystitis/painful bladder syndrome and recurrent urinary tract infections.

Authors:  Ijabla Raymond; Nikhil Vasdev; Jill Ferguson; Marion Haskin; Liz Davis; Tahseen S Hasan
Journal:  Curr Urol       Date:  2012-09-27

8.  Intravesical instillations for the treatment of refractory recurrent urinary tract infections.

Authors:  Sonia Dutta; Felicia Lane
Journal:  Ther Adv Urol       Date:  2018-02-18

Review 9.  Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier.

Authors:  C L Romanò; E De Vecchi; M Bortolin; I Morelli; L Drago
Journal:  J Bone Jt Infect       Date:  2017-01-01

10.  Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study.

Authors:  Oriana Ciani; Erik Arendsen; Martin Romancik; Richard Lunik; Elisabetta Costantini; Manuel Di Biase; Giuseppe Morgia; Eugenia Fragalà; Tomaskin Roman; Marian Bernat; Giorgio Guazzoni; Rosanna Tarricone; Massimo Lazzeri
Journal:  BMJ Open       Date:  2016-03-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.